| book details |

Polysaccharides in Cancer Therapy

Edited by Shakeel Ahmed, Edited by Meghraj Vivekanand Suryawanshi

This book is currently unavailable. Enquire to check if we can source a used copy

| enquire |

| book description |

This book provides a thorough overview of the clinical applications of polysaccharides in cancer therapy. It explores diverse types and intricate molecular structures of polysaccharides and examines their immunomodulatory properties and inherent potential as potent anticancer agents. The book also presents pharmacokinetic and pharmacodynamic properties of polysaccharides in cancer therapy, shedding light on their dynamic interactions within the body and their impact on cancer cells. It also discusses how polysaccharides can enhance traditional chemotherapy and radiation therapy outcomes, leading to more effective cancer treatment strategies. Additionally, it uncovers the vital role of polysaccharides in the burgeoning fields of cancer immunotherapy, targeted therapy, and cancer prevention, offering insights into their potential to reduce cancer risk. The integration of nanotechnology for precision drug delivery and the emerging field of theranostics are also discussed, highlighting practical clinical applications. Additionally, the book addresses crucial safety and regulatory considerations, underscores ethical and societal aspects, and elucidates the stringent regulatory approval processes governing polysaccharide-based cancer therapies. This book is intended for researchers in the fields of cancer, biomedical sciences, and pharmacology. KEY FEATURES: Provides an overview of the clinical applications of polysaccharides in cancer therapy Explores the diverse types and intricate molecular structures of polysaccharides Presents insights into the immunomodulatory properties of polysaccharides and their significant role in cancer treatment Illuminates the dynamic interactions of polysaccharides within the body, highlighting their influence on cancer cells Addresses crucial safety considerations and the stringent regulatory approval processes governing polysaccharide-based cancer therapies